Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials

Abdelhakim Allali1, Mohamed Abdel-Wahab2, Karim Elbasha3

  • 1Cardiology Department, Heart Center Segeberger Kliniken, Bad Segeberg, Germany. abdelhakim.allali@segebergerkliniken.de.

Insights

Rotational atherectomy (RA) shows improved results for calcified coronary lesions due to technical advancements and newer drug-eluting stents (DES). This analysis reviews RA

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Coronary artery calcification poses challenges for percutaneous coronary intervention.
  • Advancements in rotational atherectomy (RA) and drug-eluting stents (DES) have evolved treatment strategies.
  • Previous trials like ROTAXUS and PREPARE-CALC provide comparative data on RA versus balloon angioplasty.

Purpose of the Study:

  • To assess the technical evolution of RA in treating calcified coronary lesions.
  • To analyze RA outcomes in various patient and lesion subsets.
  • To propose recommendations for optimizing RA practice and lesion preparation.

Main Methods:

  • Pooled analysis of rotational atherectomy (RA) groups from ROTAXUS and PREPARE-CALC trials.
  • Review of recent literature on RA in calcified coronary lesions.
  • Evaluation of RA combined with other lesion preparation techniques.

Main Results:

  • Rotational atherectomy (RA) demonstrates satisfactory acute and long-term outcomes in calcified coronary lesions.
  • Technical improvements and newer generation drug-eluting stents (DES) contribute to favorable results.
  • Evidence supports RA's efficacy across diverse patient and lesion characteristics.

Conclusions:

  • Rotational atherectomy (RA) is a refined and effective modality for managing severely calcified coronary lesions.
  • A practical, evidence-based approach to RA can enhance treatment success.
  • Combining RA with other methods may further optimize lesion preparation.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
51
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
42
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
42
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
57
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
31
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
60